课题基金 / 基金详情

Molecular mechanism for immunoprotection and Treg induction by polyspecific immunoglobulins (IVIg)

Molecular mechanism for immunoprotection and Treg induction by polyspecific immunoglobulins (IVIg)
多特异性免疫球蛋白 (IVIg) 免疫保护和 Treg 诱导的分子机制
批准号：
234410
负责人：
Mazer Bruce D
金额：
$12.02万
依托单位：
Meakins Christie Labs (Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=234410&lang=en
关键词：
Allergies Asthma Cytokines Dendritic Cells Immune Modulation Intravenous Immunoglobulin T-Regulatory Cells

项目摘要

项目成果

Mazer Bruce D的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the most effective treatments for severe inflammatory and autoimmune diseases is intravenous immunoglobulin (IVIg). This treatment is made up of human antibodies derived from the plasma of many donors and is currently the most commonly prescribed p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory B-cells inhibit Allergic Airways Disease: Role of Semaphorin 4C
GET-FACTS Investigators Workshop and CSACI symposium: On the Cutting Edge of Food Allergy Research
GET-FACTS: Genetics, Environment and Therapies: Food Allergy Clinical Tolerance Studies
GET-FACTS: Genetics, Environment and Therapies: Food Allergy Clinical Tolerance Studies
海外基金